Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2009-010062-33Phase 3Completed
Phase 3, randomised, open-label trial of Foreskin fibroblast (neonatal) in stasis ulcer (2 arms), sponsored by Advanced BioHealing. Primary endpoint: Complete healing of ulcer by 16 weeks. Started Apr 2009; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2009-010062-33.